Biopharmaceutica
l Cold Chain Logistics Market
Biopharmaceutical Cold Chain Logistics Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Biopharmaceutical Cold Chain Logistics Market Size and Growth
The Biopharmaceutical Cold Chain Logistics market is experiencing significant growth, driven by increasing demand for temperature-sensitive drugs. The market is projected to reach approximately $24 billion by 2026, fueled by advancements in logistics technology, regulatory pressures, and the rising prevalence of biologics. Efficient cold chain solutions are essential for product integrity and compliance.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ FedEx Corporation
◍ Ceva Logistics LLC
◍ Amerisource Bergen Corporation
◍ Panalpina Group
◍ Kuehne + Nagel International AG
◍ XPO Logistics, Inc
◍ United Parcel Service, Inc
◍ Deutsche Post DHL Group
◍ DB Schenker
◍ C.H. Robinson Worldwide
The biopharmaceutical cold chain logistics market features key players like FedEx, Ceva, Amerisource Bergen, Panalpina, Kuehne + Nagel, XPO, UPS, DHL, DB Schenker, and C.H. Robinson. They provide temperaturecontrolled transport solutions and advanced tracking technologies, driving market growth by ensuring compliance and maintaining product integrity.
- FedEx: $84 billion
- UPS: $97.3 billion
- DHL: $92 billion
- Amerisource Bergen: $238.5 billion
- DB Schenker: $23 billion
Request Sample Report
Market Segmentation
By Application
Air Shipping
Sea Shipping
Road Shipping
Rail Shipping
Others
Request Sample Report
By Product
Active Cold Chain
Passive Cold Chain
Others
Market Growth
Request Sample Report
$ X Billion USD
